InMode shares surge 10.61% intraday amid rumors of potential $1.1B foreign acquisition.

InMode surged 10.61% intraday following reports of a potential $1.1 billion acquisition by a foreign investment fund, valuing the medical aesthetics firm at a 23.5% premium to its closing price. The deal, if finalized, would delist the company and mark a significant premium to its $963 million market cap. Israeli media and analysts highlighted the transaction as precedent-aligned with past acquisitions in the sector, while the company’s recent Q3 2025 earnings beat added short-term momentum. Bank of America was reportedly engaged to manage the sale process, further signaling the seriousness of the bid. Despite skepticism about InMode’s long-term revenue trends, the immediate catalyst drove sharp intraday gains, reflecting investor optimism about a premium exit for shareholders.